Literature DB >> 10860177

Mortality, mode of death and risk indicators for death during 5 years after coronary artery bypass grafting among patients with and without a history of diabetes mellitus.

J Herlitz1, G B Wognsen, B W Karlson, H Sjöland, T Karlsson, K Caidahl, M Hartford, M Haglid.   

Abstract

OBJECTIVE: To describe mortality, mode of death, risk indicators for death and symptoms of angina pectoris among survivors during 5 years after coronary artery bypass grafting (CABG) among patients with and without a history of diabetes mellitus.
METHODS: All patients in western Sweden who underwent CABG without concomitant valve surgery and who had no previous CABG between June 1988 and June 1991 were entered prospectively in this study. After 5 years, information on deaths that had occurred was obtained for the analysis.
RESULTS: In all, 1998 patients were included in the analysis; 242 (12%) had a history of diabetes. Among the non-diabetic patients, 5-year mortality was 12.5%; the corresponding relative risk for diabetic patients was 2.1 (95% confidence interval 1.6 to 2.9). A history of diabetes was an independent risk indicator of death; there was no significant interaction between any other risk indicator and diabetes. Independent risk indicators for death among diabetic patients were: current smoking, renal dysfunction and left ventricular ejection fraction < 0.40. Compared with non-diabetic patients, those with diabetes more frequently died in hospital, died a cardiac death, or had death associated with the development of acute myocardial infarction and with symptoms of congestive heart failure. Among survivors, diabetic patients tended to have more angina pectoris 5 years after CABG than did those without diabetes.
CONCLUSION: During a period of 5 years after CABG, diabetic patients had a mortality twice that of non-diabetic patients. The increased risk included death in hospital, cardiac death and death associated with development of acute myocardial infarction and with symptoms of congestive heart failure.

Entities:  

Mesh:

Year:  2000        PMID: 10860177     DOI: 10.1097/00019501-200006000-00007

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  13 in total

1.  Does tight glucose control prevent myocardial injury and inflammation?

Authors:  Jeremiah R Brown; Anthony P Furnary; Todd A Mackenzie; Dennis Duquette; Robert E Helm; Marco Paliotta; Cathy S Ross; David J Malenka; Gerald T O'Connor
Journal:  J Extra Corpor Technol       Date:  2011-09

Review 2.  Perioperative Management of Hyperglycemia and Diabetes in Cardiac Surgery Patients.

Authors:  Rodolfo J Galindo; Maya Fayfman; Guillermo E Umpierrez
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

3.  Diabetes and stress hyperglycemia in the intensive care unit: outcomes after cardiac surgery.

Authors:  Roma Y Gianchandani; Nazanene H Esfandiari; Jonathan W Haft; Richard L Prager; Rodica Pop-Busui
Journal:  Hosp Pract (1995)       Date:  2012-04

4.  Nitric oxide affects UbcH10 levels differently in type 1 and type 2 diabetic rats.

Authors:  Monica P Rodriguez; Nick D Tsihlis; Zachary M Emond; Zheng Wang; Vinit N Varu; Qun Jiang; Janet M Vercammen; Melina R Kibbe
Journal:  J Surg Res       Date:  2015-02-13       Impact factor: 2.192

Review 5.  Advances in diabetes for the millennium: diabetes and cholesterol.

Authors:  Marc Rendell
Journal:  MedGenMed       Date:  2004-10-06

6.  Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys.

Authors:  K Pyörälä; S Lehto; D De Bacquer; J De Sutter; S Sans; U Keil; D Wood; G De Backer
Journal:  Diabetologia       Date:  2004-07-02       Impact factor: 10.122

7.  Angiographic characteristics of the coronary artery in patients with type 2 diabetes.

Authors:  Tong-Guo Wu; Lexin Wang
Journal:  Exp Clin Cardiol       Date:  2002

8.  Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.

Authors:  Sadaf S Ahanchi; Vinit N Varu; Nick D Tsihlis; Janet Martinez; Charles G Pearce; Muneera R Kapadia; Qun Jiang; Joseph E Saavedra; Larry K Keefer; Joseph A Hrabie; Melina R Kibbe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-17       Impact factor: 4.733

9.  Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial.

Authors:  Guillermo Umpierrez; Saumeth Cardona; Francisco Pasquel; Sol Jacobs; Limin Peng; Michael Unigwe; Christopher A Newton; Dawn Smiley-Byrd; Priyathama Vellanki; Michael Halkos; John D Puskas; Robert A Guyton; Vinod H Thourani
Journal:  Diabetes Care       Date:  2015-07-15       Impact factor: 19.112

10.  Cardiovascular risk factor management of myocardial infarction patients with and without diabetes in the Netherlands between 2002 and 2006: a cross-sectional analysis of baseline data.

Authors:  Sabita S Soedamah-Muthu; Johanna M Geleijnse; Erik J Giltay; Daan Kromhout
Journal:  BMJ Open       Date:  2012-10-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.